Israeli pharmaceutical concern «Teva» intends in the coming days to announce massive layoffs in Israel.
As «kalkalist», which is in financial difficulty, the Corporation plans to lay off 1,700 from 6.680 Israeli workers.
Also there are plans for significant layoffs in the United States.
The decision on mass dismissals in the framework of the reorganization and efficiency adopted by the company’s management, headed by new CEO Carol Schultz.
Parallel terminated a contract with a Deputy Director for research and development Michael Hydnum responsible for the development of new drugs.
According to «Calcalist», a new series of layoffs not associated with the dismissal of 350 employees, which the Corporation announced in August of this year.